In Arizona, individuals and patients who paid for clinical laboratory tests performed by Theranos, Inc., are finally getting refunds. These payments are a result of a settlement between the Arizona Attorney General and Theranos. News accounts indicate that, over the time in 2013 through 2016 that Theranos offered lab tests in Arizona through its relationship with Walgreens, about 175,000 patients were tested. It is reported that the average refund will be $61. One Arizona resident paid $3,400 to Theranos for clinical laboratory tests.
HEALTH NETWORK LABS EXPANDS INTO FOUR HOSPITALS
In Allentown, Pa., Health Network Laboratories (HNL) disclosed last month that it will assume management of inpatient laboratories at four hospitals in northeast Pennsylvania. Each of these hospitals was acquired by HNL’s parent, Lehigh Valley Health Network. HNL says that it now manages seven hospital laboratories.
GENOPTIX ACQUIRES ROSETTA GENOMICS
Last month, Genoptix announced a merger agreement with Rosetta Genomics. The acquisition of outstanding Rosetta shares is valued at $10 million, or about 60¢ per share. Rosetta’s CEO said that there was only enough cash to fund operations through the end of 2017.
- CEO Khosrow Shotorbani resigned from TriCore Reference Laboratories in December to pursue other opportunities. He previously held executive positions at ARUP Laboratories.
- Last month, Priscilla Cherry retired from her position as Vice President of Laboratory and Courier Services at Mission Health Systems. Formerly, Cherry held administrative positions at Fairview Health Services, Premiere Inc., and Kaiser Permanente.
- Ana K. Stankovic, MD, retires from Becton Dickinson this month. She held positions at the Centers for Disease Control and Prevention, Quest Diagnostics, Immucor, and the American Red Cross.
- Ambry Genetics announced the selection of Tom Schoenherr as its new Chief Commercial Officer. Schoenherr has had executive positions with Counsyl, Quest Diagnostics, Siemens Healthcare, and Abbott Diagnostics.
That’s all the insider intelligence for this report.
Look for the next briefing on Monday, January 22, 2018.
Have you caught the latest e-briefings from DARK Daily? If so, then you’d know about …
…how researchers in the Netherlands published findings about their verification that at least 30,000 studies published in 33,000 scientific papers included data derived from misidentified or contaminated cell lines. This puts at risk many findings in the fields of oncology, molecular biology, pharmacology, and other cell-centric medical research.
You can get the free DARK Daily e-briefings by signing up at www.darkdaily.com.